Allogeneic heart transplantation activates alloreactive NK cells

Cellular Immunology
E PeterssonG Hedlund

Abstract

The ability of natural killer (NK) cells to recognize and reject transplants has so far been shown in hematopoietic grafts only. This study was designed to ascertain whether NK cells may also be involved in the rejection of transplanted organs. In most rat strain combinations, immunization with allogeneic cells induces a T cell response with cytotoxic T lymphocyte (CTL) activation. We have previously found one exception to this. In contrast to Wistar Furth rats (WF, RT1u), which manifest allospecific CTL activation in response to immunization with Brown Norway (BN, RT1n) cells, BN rats immunized with repeated intraperitoneal (i.p.) injections of allogeneic WF spleen cells manifest activation of alloreactive NK effector cells. The alloreactive NK cells were of the TCR-, CD3-, CD8+, and NKR-P1 intermediate phenotype and killed target cells with alloselectivity. In this study we used a heart transplantation model to study the rejection response of BN rats receiving WF grafts. NK cell infiltration was greater in WF hearts transplanted to BN recipients than in BN hearts transplanted to WF recipients. Furthermore, the extent of T cell infiltration was less in BN recipients. In WF rats transplanted with allogeneic BN hearts, CTL were ...Continue Reading

Citations

Dec 22, 1999·The Journal of Clinical Investigation·J TrambleyC P Larsen
Apr 9, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Wei LiJames D Perkins
Aug 13, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Hideaki ObaraSheri M Krams
Apr 24, 2009·Transplant International : Official Journal of the European Society for Organ Transplantation·Johann PratschkeKatja Kotsch
Feb 14, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M E McNerneyM-L Alegre
Mar 31, 2006·Human Immunology·Amal BisharaRifaat Safadi
Feb 1, 2006·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Patricia AguilarMarie C Bene
Oct 28, 2016·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·C M LinR G Gill
Jan 1, 2008·Expert Review of Clinical Immunology·Suraksha AgrawalSita Naik
Sep 22, 1999·Gene Therapy·N GiannoukakisP Robbins
Apr 27, 1997·Transplantation·E PeterssonG Hedlund
Feb 27, 2015·Transplantation·Zhu-Xu ZhangAnthony M Jevnikar
Feb 1, 2007·Current Opinion in Organ Transplantation·Maria-Luisa Alegre, Megan E McNerney
Jan 15, 2008·Transplantation·Lu-En WaiSheri M Krams
Mar 30, 2006·Transplantation·William H KitchensJoren C Madsen
Jun 13, 2017·The Journal of Clinical Investigation·Nicole M Valenzuela, Elaine F Reed
Aug 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shuichiro UeharaJoren C Madsen
Jul 29, 2016·World Journal of Gastroenterology : WJG·René FahrnerFalk Rauchfuss

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.